Susquehanna International Group, LLP Abbott Laboratories Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $59 Million - $69.7 Million	589,900 Added 61.61%	1,547,300 $176 Million
Q2 2024 Aug 15, 2024	SELL	$100.73 - $112.44 $31 Million - $34.6 Million	-308,000 Reduced 24.34%	957,400 $99.5 Million
Q1 2024 May 07, 2024	SELL	$109.52 - $120.96 $31.6 Million - $34.9 Million	-288,600 Reduced 18.57%	1,265,400 $144 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $32.2 Million - $39.5 Million	357,400 Added 29.87%	1,554,000 $171 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $65.8 Million - $78.9 Million	-688,400 Reduced 36.52%	1,196,600 $116 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $85.7 Million - $95.5 Million	850,500 Added 82.21%	1,885,000 $206 Million
Q1 2023 May 16, 2023	SELL	$96.86 - $114.01 $47.6 Million - $56 Million	-491,300 Reduced 32.2%	1,034,500 $105 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $24.4 Million - $28.7 Million	-257,100 Reduced 14.42%	1,525,800 $168 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $71.8 Million - $83.1 Million	742,100 Added 71.3%	1,782,900 $173 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.